[Potentiation of antineoplastic agents--significance of combination with urokinase].
作者信息
Yamamoto M, Yamada T, Fukunaga K, Nagashima A, Nagamatsu S
出版信息
Gan No Rinsho. 1971 Oct;17(10):750-9.
PMID:5166830
Abstract
摘要
相似文献
1
[Potentiation of antineoplastic agents--significance of combination with urokinase].[抗肿瘤药物的增效作用——与尿激酶联合使用的意义]
Gan No Rinsho. 1971 Oct;17(10):750-9.
2
3
4
[Chemotherapy of cancer--theory and practice].[癌症的化学疗法——理论与实践]
Naika. 1971 Oct;28(4):657-64.
5
Experimental study on combined therapy with anticancer drugs and urokinase.抗癌药物与尿激酶联合治疗的实验研究
Sci Rep Res Inst Tohoku Univ Med. 1973 Dec;19(4):138-45.
6
[Clinical study for augmentation of efficacy of anticancer drugs. 1. Combination therapy by proteolytic enzyme and anticancer drugs].[抗癌药物疗效增强的临床研究。1. 蛋白水解酶与抗癌药物的联合治疗]
Nihon Gan Chiryo Gakkai Shi. 1972 Dec 20;7(4):270-8.
7
[Synergic effects of lysosome labilizer and anti-neoplastic agents with special reference to the effects of plasmin and mitomycin-C].[溶酶体稳定剂与抗肿瘤药物的协同作用，特别提及纤溶酶和丝裂霉素-C的作用]
Saishin Igaku. 1968 Oct 10;23(10):2168-72.
8
[Antitumoral chemotherapy].[抗肿瘤化疗]
Acta Clin Belg. 1974;29(1):1-19. doi: 10.1080/17843286.1974.11716896.
9
[Study of the action of antitumor compounds on primary explants from human tumors].
Antibiotiki. 1967 Sep;12(9):803-7.
10
Clinical cancer chemotherapy aimed at potential cell regulators.针对潜在细胞调节因子的临床癌症化疗。
Arch Surg. 1970 Feb;100(2):167-72. doi: 10.1001/archsurg.1970.01340200055013.
Zotero 插件